Population
In vitro models studying the guanylate-binding protein (GBP) gene promoter
Design
Preclinical
Authors
Loading...
Does not yet inform clinical IFN use; leaves open selective pathway targeting in cardiovascular research.
Demonstrates that alpha-interferon activates transcription of the GBP gene via two distinct signal transduction pathways involving different DNA-binding proteins.
Decker et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: